In this webinar recording, Marlin Frechette discusses:
The critical factors in choosing the right raw materials for cell culture media development
The quality attribute considerations for testing and quality controls of raw materials for cryopreservation media
How to get the proper regulatory support from your supplier to ensure the safety and efficacy of the media
Why a close partnership with your supplier can accelerate the development process all the way to therapy
Topic: Using AI to Gain a Clearer Picture of Embryo Quality Presenter: Dr. Jonathan Hall, PhD Co-Founder, Director & Chief Scientist, MIT Tech Review Innovator | InDaily 40u40 Alumni Presenter: Dr. Colin Lee, FRCOG (United Kingdom), MBBS (Australia), M.Med (Singapore), Medical Director Founder of Alpha IVF Group Posted in: Assisted Reproductive Technology
Dr. Jonathan Hall's presentation focuses on the development of the AI-based platform, Life Whisperer, it's performance, and the combined use of Life Whisperer Viability and Genetics. Dr. Colin Lee's presentation focuses on the customer experience of using Life Whisperer, the implementation of it in the clinic, and how the use of Life Whisperer helps in the decision making process of embryo selection and streamlines the clinic's workflow.
Topic: Global Perspectives on Bringing AI to Life in your IVF Workflow Chair: Dr. Matthew ‘Tex’ VerMilyea, Vice President of Scientific Advancement at Ovation Fertility Panelist: Dr. Michelle Perugini, CEO at Presagen Panelist: Dr. Marcos Meseguer, Scientific Supervisor, IVI Valencia Panelist: Dr. Vipin Chandra, Chief of Clinical and Lab Operations at Indira IVF, India Posted in: Assisted Reproductive Technology
This is a recording of the FUJIFILM Irvine Scientific ESHRE 2023 Company Session. In it, we discuss how AI can be used for embryo selection.
In this webinar recording, Dr. Shahram Shahabi discusses how to avoid inconsistencies associated with standard cell culture media including: animal serum, ill-defined factors, batch-to-batch variability in composition, and the risk of contamination.
This webinar will provide the insight to help you:
Uncover the potential and benefits of chemically defined (CD), serum-free cell culture media
Discuss the scientific concerns about cell culturing with serum
Discover how to make the switch from serum-based media to chemically defined media
Topic: A Review – When to Transfer and What to Transfer? Presenter: Charles Bormann, PhD, HCLD, Laboratory Director, Massachusetts General Hospital Presenter: Antonio Alcaide Raya, MSc, European Technical Application Scientist, FUJIFILM Irvine Scientific Posted in: Assisted Reproductive Technology
In this webinar, we review the benefits of both Day 3 and Day 5 embryo transfers, including the importance of acknowledging why both have a place in IVF. We also discuss the different embryo AI-based assessment tools currently available for Day 5 embryos, and why non-time-lapse technologies and non-video based applications like Life Whisperer Viability could help improve in the selection of more viable embryos to achieve higher clinical pregnancy rates.
In this webinar, we provide insights into CSCM-NX and Heavy Oil for Embryo Culture. The discussion includes topics such as what we thought we knew about lactate concentrations in embryo culture media, the exciting new discoveries made through clinical studies and data analysis, and what we have seen in emerging peer reviewed literature regarding embryonic gene expression and biomarkers. We also discuss how to choose the right oil for your lab, and the role oil can play in creating the optimal embryo culture environment.
Topic: Revisiting low-lactate culture media 5 years later – how to make it work for your lab Speaker: Matthew ‘Tex’ VerMilyea, PhD, HCLD/CC (ABB) on behalf of Lindsey VerMilyea, MSc (Austin, Texas, USA)
Topic: A Clearer Picture of Embryo Viability with AI-based Technology Speaker: Michelle Perugini, PhD (San Francisco, California, California, USA) Speaker: Nuria Soler, PhD (Alicante, Spain) Speaker: Matthew ‘Tex’ VerMilyea, PhD, HCLD/CC (ABB) (Austin, Texas, USA)
IVF regulations worldwide are continuously changing. In this workshop from ESHRE 2022, Marlin Frechette reviews recent changes in the European Standards and what our organization is doing as a company to meet the Medical Device Regulations (MDR) requirements to continue providing products to customers without interruption.
In this presentation made at BPI West 2022, Tom Fletcher, R&D Director, Process Development, FUJIFILM Irvine Scientific discusses the many benefits of the new Manufacturing Science and Technology (MSAT) service. MSAT can help to develop user-friendly cell culture media for late-stage development, and the manufacturing of biologic drug substances and cell and gene therapies, identify opportunities for practical improvement of existing solution preparation processes, and simplify media preparation methods and improving solubility of powdered media.
In this presentation, given at BPI EU 2021, Tom Fletcher, R&D Director, Process Sciences, introduces the new Manufacturing Science and Technology (MSAT) service, which was created in response to the needs of biopharmaceutical manufacturers for better cell culture media preparation methods. Whether the needs are to reduce cost, save time, or improve reliability, the MSAT service helps identify opportunities for practical improvement of existing solution preparation processes. Case studies are provided as examples of various approaches.
Topic: Life Whisperer Viability Webinar Series Presenter: Dr. Michelle Perugini, Founder & CEO of Presagen Presenter: Matthew VerMilyea, PhD, HCLD/CC (ABB); Vice President of Scientific Advancement – Ovation Fertility; Scientific Director – Texas Fertility Centers; Laboratory and Operations Director – Ovation Fertility Austin & San Antonio Presenter: Adelle Lim, MSc Posted in: Assisted Reproductive Technology
Watch this webinar to gain a deeper understanding of how an AI-based tool can significantly improve embryo assessment. Life Whisperer Viability, an objective, non invasive web application that uses AI-based analysis to assess embryo viability can significantly improve your confidence in the embryo selection process.
At the 2021 Multi-Functional Cell Therapies (MFCT) Summit, Robert Newman, PhD, CSO, FUJIFILM Irvine Scientific, presented innovative approaches that his R&D team uses to select and optimize versatile, chemically defined media, as well as how these efforts drive the successful development and production of combination biotherapies.
Session: Leading the Way in IVF through Innovative Solutions Chair: Robert Newman, PhD, Chief Scientific Officer, FUJIFILM Irvine Scientific Presenter: Nadir Ciray, PhD, R&D Director – ART, FUJIFILM Irvine Scientific Presenter: Matthew (Tex) VerMilyea, PhD, HCLD/CC (ABB), Vice President of Scientific Advancement, Ovation Fertility Posted in: Assisted Reproductive Technology
Topic: Developing and Understanding Perfusion Processes Presented by: Véronique Chotteau, Principal Investigator of the Cell Technology Group, KTH Royal Institute of Technology Presented by: Tom Fletcher, Director – Process Development, FUJIFILM Irvine Scientific Posted in: Bioproduction
This session, which was part of the BPI Fall Digital Week Webinar Series, features recent results from insightful studies conducted at KTH Royal Institute of Technology in Stockholm, along with an update on efforts to develop superior chemically-defined cell culture media from FUJIFILM Irvine Scientific.
The transportation of cryopreserved specimens, especially those that are slow-frozen, is a routine activity for most IVF laboratories. In this webinar, led by Dr. Dunja Baston-Büst, we focus on the transportation of vitrified specimens that are particularly sensitive to their surroundings—and discuss the specific conditions and steps that should be taken to help ensure their intact transport and storage.
In this webinar, Holden Harris shares a behind the scenes look into our assisted reproductive technology (ART) media development process, providing insight into work done during product design and testing during design control. Get a closer look into how we ensure that our media meets rigorous quality, safety, and performance criteria before going to market.
This webinar explores the specific regulatory requirements of different regions (including analysis of the amount of time the regulatory approval process takes in each case), and the critical quality attributes (CQAs) of cell therapy raw and starting materials.
In this webinar, Joseph Conaghan, PhD, and Nadir Ciray, PhD, discuss the basics of vitrification media components and review how vitrification media has evolved to suit the needs of the modern IVF laboratory.
In this webinar, Joseph Conaghan, PhD, shares some helpful tips on how to simplify procedures in micromanipulation, oocyte vitrification and embryo culture in order to maximize successful outcomes in the IVF laboratory.
In this webinar, Yannis Panagiotidis, discusses closed system vitrification.
Session: Next Generation Embryo Culture and Vitrification Systems Chair: Yannis Panagiotidis, PhD, Head of IVF Lab, Lakentro IVF Unit, Thessaloniki, Greece Presenter: Yosu Franco Iriarte, PhD, Laboratory Director, Hospital Ruber International, Madrid, Spain Presenter: Ahmad Morsi Abu Maizar, M.Sc., Senior Clinical Embryologist, California Fertility Partners, Los Angeles, California USA Posted in: Assisted Reproductive Technology
Learn more about how FUJIFILM Irvine Scientific helps manufacturers through the raw materials qualification process and regional regulatory approvals, so that they can better address the challenges and opportunities on the road to bringing cell therapies to market.